Important : this page, dedicated to investors, provides information common to Sfil and CAFFIL. To access additional information specific to each entity, please visit sfil.fr or caffil.fr.
Group presentation
Sfil has the legal status of a public development bank under European Union regulations.
As a strategic subsidiary of CDC Group, Sfil benefits from a letter of support provided by CDC, complemented by
a letter of support by the French Republic.
The scope of business is limited to two public policy missions, the financing of investments by French local authorities,
and the financing of French export contracts guaranteed by the French Republic.
2022 was marked by strong financial results which underline the performance of the public development bank
business model of Sfil.
Credit ratings of Sfil are directly aligned with the ratings of the French Republic, with and an additional rating
pick-up for covered bonds issued by Caffil.
The ambitious sustainability strategy of the group has been confirmed by strong ESG ratings for Sfil and Caffil
by Sustainalytics and ISS.
Sfil is a regular issuer in the SSA market and in the covered bond market via Caffil.
Total yearly issuance is between EUR 7 and 9 billion and ESG issuance represents a growing share of issuance,
with a target of 25% of issuance under ESG format by 2024.